DZ Bank’s Actinium Pharmaceuticals ATNM Stock Holding History

DZ Bank’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,752	Closed	-$41K	–	866
2018 Q1	$41K	Buy	+3,752	New	+$63.8K	﹤0.01%	1042

Other funds holding ATNM

DAM

DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

DZ Bank's ATNM Position: Q2 2018 in Review

DZ Bank sold out of Actinium Pharmaceuticals (ATNM) in Q2 2018, closing a stake of 3,752 shares — an estimated $41K sold.

DZ Bank first reported a position in ATNM in Q1 2018 and held it in 1 quarter. The position peaked at $41K in Q1 2018. 42 funds tracked by Wall St. Rank hold ATNM as of Q2 2018.

DZ Bank reported no remaining Actinium Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 3,752 Actinium Pharmaceuticals shares in Q2 2018, an estimated $41K.
DZ Bank first reported a position in Actinium Pharmaceuticals in Q1 2018 and held it in 1 quarter.
DZ Bank's Actinium Pharmaceuticals position peaked at $41K in Q1 2018.
42 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.